关注
Paul Burke
Paul Burke
Principal, Burke Bioventures LLC
在 burkebio.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
S Mitragotri, PA Burke, R Langer
Nature reviews Drug discovery 13 (9), 655-672, 2014
16632014
Improving protein therapeutics with sustained-release formulations
SD Putney, PA Burke
Nature biotechnology 16 (2), 153-157, 1998
6561998
Methods for fabricating polymer-based controlled release devices
MA Tracy, JD Herberger, PA Burke, PF Herbert
US Patent 5,989,463, 1999
4001999
Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment
MT Abrams, ML Koser, J Seitzer, SC Williams, MA DiPietro, W Wang, ...
Molecular therapy 18 (1), 171-180, 2010
2122010
Method for fabricating polymer-based controlled-release devices
PA Burke
US Patent 5,817,343, 1998
1921998
A potential approach for decreasing the burst effect of protein from PLGA microspheres
K Fu, R Harrell, K Zinski, C Um, A Jaklenec, J Frazier, N Lotan, P Burke, ...
Journal of pharmaceutical sciences 92 (8), 1582-1591, 2003
1682003
Composition for sustained release of non-aggregated erythropoietin
SE Zale, PA Burke, H Bernstein, A Brickner
US Patent 5,716,644, 1998
1551998
Composition for sustained release of non-aggregated erythropoietin
SE Zale, PA Burke, H Bernstein, A Brickner
US Patent 5,674,534, 1997
1481997
Microencapsulation and sustained release of oligonucleotides
PA Burke
US Patent 6,265,389, 2001
1342001
Solid-state NMR assessment of enzyme active center structure under nonaqueous conditions.
PA Burke, RG Griffin, AM Klibanov
Journal of Biological Chemistry 267 (28), 20057-20064, 1992
1171992
Quantitative evaluation of siRNA delivery in vivo
Y Pei, PJ Hancock, H Zhang, R Bartz, C Cherrin, N Innocent, ...
Rna 16 (12), 2553-2563, 2010
942010
Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa
XC Nguyen, JD Herberger, PA Burke
Pharmaceutical Research 21, 507-514, 2004
922004
Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles
R Crawford, B Dogdas, E Keough, RM Haas, W Wepukhulu, S Krotzer, ...
International journal of pharmaceutics 403 (1-2), 237-244, 2011
872011
Solid‐state nuclear magnetic resonance investigation of solvent dependence of tyrosyl ring motion in an enzyme
PA Burke, RG Griffin, AM Klibanov
Biotechnology and bioengineering 42 (1), 87-94, 1993
811993
Method for fabricating polymer-based controlled-release devices
PA Burke
US Patent 6,183,781, 2001
752001
Demonstration of structural integrity of an enzyme in organic solvents by solid-state NMR
PA Burke, SO Smith, WW Bachovchin, AM Klibanov
Journal of the American Chemical Society 111 (21), 8290-8291, 1989
751989
Poly (lactide-co-glycolide) microsphere formulations of darbepoetin alfa: spray drying is an alternative to encapsulation by spray-freeze drying
PA Burke, LA Klumb, JD Herberger, XC Nguyen, RA Harrell, M Zordich
Pharmaceutical research 21, 500-506, 2004
732004
Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses
W Tao, X Mao, JP Davide, B Ng, M Cai, PA Burke, AB Sachs, ...
Molecular Therapy 19 (3), 567-575, 2011
722011
Determination of internal pH in PLGA microspheres using 31P NMR spectroscopy
PA Burke
Proc Int Symp Control Release Bioact Mater 23 (133), e134, 1996
511996
Advancing polymeric delivery systems amidst a nucleic acid therapy renaissance
PA Burke, SH Pun, TM Reineke
ACS macro letters 2 (10), 928-934, 2013
412013
系统目前无法执行此操作,请稍后再试。
文章 1–20